Olive Oil Supplementation for Heart Failure With Reduced Ejection Fraction
Sponsor: Old Dominion University • ClinicalTrials.gov ID: NCT07644806
Recruiting for Similar Conditions?
Sponsors are looking for patients like you. See if you qualify for compensated research studies.
Check Eligibility →Description
The OLEA-HF study aims to explore whether daily supplementation of extra-virgin olive oil (EVOO) for 12 weeks during participation in a cardiac rehabilitation program (standard of care) is feasible in patients with heart failure with reduced ejection fraction (HFrEF). The investigators will also determine the effects of EVOO on functional capacity and quality of life.
Interventions
-
Extra-virgin olive oil
(Other)
At least 4 tablespoons of extra-virgin olive oil per day
Eligibility criteria
Conditions
Locations
- Strelitz Diabetes Center (Williams Hall) — Norfolk, Virginia, United States
Partner with Nurenyx
Showcase your study to thousands of motivated patients matching your criteria.
Learn MoreOfficial Source
Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
View Official Record